source Post navigation Eli Lilly's Tirzepatide Reduces Type 2 Diabetes Risk by 94% in L – GuruFocus.com Hopkins alum leads Eledon Pharmaceuticals in breakthrough diabetes tegoprubart treatment – Johns Hopkins News-Letter